{"id":"https://openalex.org/W2498896723","doi":"https://doi.org/10.1016/j.biologicals.2016.06.005","title":"Determination of critical quality attributes for monoclonal antibodies using quality by design principles","display_name":"Determination of critical quality attributes for monoclonal antibodies using quality by design principles","publication_year":2016,"publication_date":"2016-07-26","ids":{"openalex":"https://openalex.org/W2498896723","doi":"https://doi.org/10.1016/j.biologicals.2016.06.005","mag":"2498896723","pmid":"https://pubmed.ncbi.nlm.nih.gov/27461239"},"language":"en","primary_location":{"id":"doi:10.1016/j.biologicals.2016.06.005","doi":"https://doi.org/10.1016/j.biologicals.2016.06.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biologicals.2016.06.005","pdf_url":null,"source":{"id":"https://openalex.org/S110177920","display_name":"Biologicals","issn_l":"1045-1056","issn":["1045-1056","1095-8320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074306007","display_name":"Nadja Alt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nadja Alt","raw_affiliation_strings":["Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: nadja.alt@roche.com","Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: nadja.alt@roche.com","institution_ids":[]},{"raw_affiliation_string":"Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002548901","display_name":"Taylor Y. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taylor Y. Zhang","raw_affiliation_strings":["Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061252646","display_name":"Paul A. Motchnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Motchnik","raw_affiliation_strings":["Biologics Quality Control, Genentech, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologics Quality Control, Genentech, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082391291","display_name":"Ron Taticek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ron Taticek","raw_affiliation_strings":["Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029179337","display_name":"Valerie E. Quarmby","orcid":"https://orcid.org/0000-0002-1043-7973","observed_orcids":["https://orcid.org/0000-0002-1043-7973"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valerie Quarmby","raw_affiliation_strings":["Research and Early Development, Genentech, South San Francisco, CA 94080 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Early Development, Genentech, South San Francisco, CA 94080 USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013013933","display_name":"Tilman Schlothauer","orcid":"https://orcid.org/0000-0001-5844-4438","observed_orcids":["https://orcid.org/0000-0001-5844-4438"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tilman Schlothauer","raw_affiliation_strings":["Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103417432","display_name":"Hermann Beck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Hermann Beck","raw_affiliation_strings":["Pharma Technical Development Biotech Europe, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Development Biotech Europe, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016075040","display_name":"Thomas Emrich","orcid":"https://orcid.org/0000-0003-1179-4697","observed_orcids":["https://orcid.org/0000-0003-1179-4697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Emrich","raw_affiliation_strings":["Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043951081","display_name":"Reed J. Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reed J. Harris","raw_affiliation_strings":["Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074306007"],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.8189,"has_fulltext":false,"cited_by_count":308,"citation_normalized_percentile":{"value":0.88111643,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"44","issue":"5","first_page":"291","last_page":"305"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.2824999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/critical-quality-attributes","display_name":"critical quality attributes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.8389999866485596},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9950000047683716},{"id":"https://openalex.org/keywords/biopharmaceuticals","display_name":"biopharmaceuticals","score":0.7570000290870667},{"id":"https://openalex.org/keywords/risk-assessment","display_name":"risk assessment","score":0.906000018119812},{"id":"https://openalex.org/keywords/risk-prioritization","display_name":"risk prioritization","score":0.7120000123977661},{"id":"https://openalex.org/keywords/recombinant-protein-expression","display_name":"recombinant protein expression","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/process-knowledge","display_name":"process knowledge","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.9078042507171631},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.8914660215377808},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.5951141119003296},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5587862133979797},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.5372306108474731},{"id":"https://openalex.org/C189430467","wikidata":"https://www.wikidata.org/wiki/Q7293293","display_name":"Ranking (information retrieval)","level":2,"score":0.5274403691291809},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.5109276175498962},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.4923006296157837},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4797567129135132},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4491429924964905},{"id":"https://openalex.org/C178144697","wikidata":"https://www.wikidata.org/wiki/Q2111609","display_name":"Process analytical technology","level":3,"score":0.4480472505092621},{"id":"https://openalex.org/C125611927","wikidata":"https://www.wikidata.org/wiki/Q17008131","display_name":"Criticality","level":2,"score":0.44621166586875916},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.41260066628456116},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.3301064670085907},{"id":"https://openalex.org/C201995342","wikidata":"https://www.wikidata.org/wiki/Q682496","display_name":"Systems engineering","level":1,"score":0.3294890522956848},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.3240286111831665},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2775120139122009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22382822632789612},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.16716700792312622},{"id":"https://openalex.org/C174998907","wikidata":"https://www.wikidata.org/wiki/Q357662","display_name":"Work in process","level":2,"score":0.16099855303764343},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13384580612182617},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.12461858987808228},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.10688760876655579},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10449442267417908},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.biologicals.2016.06.005","doi":"https://doi.org/10.1016/j.biologicals.2016.06.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biologicals.2016.06.005","pdf_url":null,"source":{"id":"https://openalex.org/S110177920","display_name":"Biologicals","issn_l":"1045-1056","issn":["1045-1056","1095-8320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals","raw_type":"journal-article"},{"id":"pmid:27461239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27461239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals : journal of the International Association of Biological Standardization","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W1191527629","https://openalex.org/W1483007604","https://openalex.org/W1518819083","https://openalex.org/W1588988525","https://openalex.org/W1813565620","https://openalex.org/W1975186623","https://openalex.org/W1976548137","https://openalex.org/W1977937625","https://openalex.org/W1979626824","https://openalex.org/W1985522044","https://openalex.org/W1986030144","https://openalex.org/W2000784356","https://openalex.org/W2012557883","https://openalex.org/W2016901072","https://openalex.org/W2019183242","https://openalex.org/W2026810188","https://openalex.org/W2027173302","https://openalex.org/W2029248360","https://openalex.org/W2039790548","https://openalex.org/W2046766109","https://openalex.org/W2058775948","https://openalex.org/W2058886266","https://openalex.org/W2061518680","https://openalex.org/W2066856346","https://openalex.org/W2071095038","https://openalex.org/W2071304375","https://openalex.org/W2075219903","https://openalex.org/W2079579628","https://openalex.org/W2084136419","https://openalex.org/W2084731542","https://openalex.org/W2086437884","https://openalex.org/W2088494830","https://openalex.org/W2092638671","https://openalex.org/W2094309883","https://openalex.org/W2104504238","https://openalex.org/W2110500887","https://openalex.org/W2124847934","https://openalex.org/W2130350426","https://openalex.org/W2137354517","https://openalex.org/W2138572955","https://openalex.org/W2140035322","https://openalex.org/W2140604498","https://openalex.org/W2143380331","https://openalex.org/W2151682079","https://openalex.org/W2152155460","https://openalex.org/W2155819450","https://openalex.org/W2165467521","https://openalex.org/W2175291039","https://openalex.org/W2323750312","https://openalex.org/W2328166159","https://openalex.org/W2496604731","https://openalex.org/W2506104693","https://openalex.org/W2512140672","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2512140672","https://openalex.org/W2903322457","https://openalex.org/W2495280803","https://openalex.org/W2030899178","https://openalex.org/W2480937959","https://openalex.org/W2520564571","https://openalex.org/W1973789918","https://openalex.org/W1999481657","https://openalex.org/W3205151650","https://openalex.org/W2027792997"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":30},{"year":2025,"cited_by_count":33},{"year":2024,"cited_by_count":42},{"year":2023,"cited_by_count":35},{"year":2022,"cited_by_count":40},{"year":2021,"cited_by_count":29},{"year":2020,"cited_by_count":35},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-08-23T00:00:00"}